NLS Pharmaceutics Ltd (NLSP)
0.4097
+0.26
(+176.26%)
USD |
NASDAQ |
Jun 18, 10:20
NLS Pharmaceutics Research and Development Expense (Quarterly)
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
Date | Value |
---|
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
AC Immune SA | 17.35M |
CRISPR Therapeutics AG | 76.17M |
Addex Therapeutics Ltd | 0.2049M |
Molecular Partners AG | 16.14M |
MoonLake Immunotherapeutics | 13.01M |